These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25801435)

  • 21. Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection.
    Kewcharoenwong C; Rinchai D; Utispan K; Suwannasaen D; Bancroft GJ; Ato M; Lertmemongkolchai G
    Sci Rep; 2013 Nov; 3():3363. PubMed ID: 24285369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.
    Xiao W; Jiang LF; Deng XZ; Zhu DY; Pei JP; Xu ML; Li BJ; Wang CJ; Zhang JH; Zhang Q; Zhou ZX; Ding WL; Xu XD; Yue M
    Immunol Res; 2016 Apr; 64(2):412-23. PubMed ID: 26286967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response to Burkholderia pseudomallei.
    Panomket P
    J Med Assoc Thai; 2011 Nov; 94(11):1410-7. PubMed ID: 22256484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity to Burkholderia pseudomallei.
    Wiersinga WJ; van der Poll T
    Curr Opin Infect Dis; 2009 Apr; 22(2):102-8. PubMed ID: 19276877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bacterial gene lfpA influences the potent induction of calcitonin receptor and osteoclast-related genes in Burkholderia pseudomallei-induced TRAP-positive multinucleated giant cells.
    Boddey JA; Day CJ; Flegg CP; Ulrich RL; Stephens SR; Beacham IR; Morrison NA; Peak IR
    Cell Microbiol; 2007 Feb; 9(2):514-31. PubMed ID: 16987331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment.
    Krönig H; Kremmler L; Haller B; Englert C; Peschel C; Andreesen R; Blank CU
    Eur J Haematol; 2014 Mar; 92(3):195-203. PubMed ID: 24175978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seropositivity to Burkholderia pseudomallei does not reflect the development of cell-mediated immunity.
    Lazzaroni SM; Barnes JL; Williams NL; Govan BL; Norton RE; LaBrooy JT; Ketheesan N
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S66-70. PubMed ID: 19121692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-1/PD-Ls pathways between CD4(+) T cells and pleural mesothelial cells in human tuberculous pleurisy.
    Yin W; Tong ZH; Cui A; Zhang JC; Ye ZJ; Yuan ML; Zhou Q; Shi HZ
    Tuberculosis (Edinb); 2014 Mar; 94(2):131-9. PubMed ID: 24406080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent infection due to a small-colony variant of Burkholderia pseudomallei leads to PD-1 upregulation on circulating immune cells and mononuclear infiltration in viscera of experimental BALB/c mice.
    See JX; Chandramathi S; Abdulla MA; Vadivelu J; Shankar EM
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005702. PubMed ID: 28820897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melioidosis Patient Survival Correlates With Strong IFN-γ Secreting T Cell Responses Against Hcp1 and TssM.
    Sengyee S; Yarasai A; Janon R; Morakot C; Ottiwet O; Schmidt LK; West TE; Burtnick MN; Chantratita N; Brett PJ
    Front Immunol; 2021; 12():698303. PubMed ID: 34394091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils.
    Woodman ME; Worth RG; Wooten RM
    PLoS One; 2012; 7(12):e52276. PubMed ID: 23251706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD14 impairs host defense against gram-negative sepsis caused by Burkholderia pseudomallei in mice.
    Wiersinga WJ; de Vos AF; Wieland CW; Leendertse M; Roelofs JJ; van der Poll T
    J Infect Dis; 2008 Nov; 198(9):1388-97. PubMed ID: 18855560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity.
    Morris J; Williams N; Rush C; Govan B; Sangla K; Norton R; Ketheesan N
    Infect Immun; 2012 Jun; 80(6):2089-99. PubMed ID: 22473609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.
    Hassan SS; Akram M; King EC; Dockrell HM; Cliff JM
    PLoS One; 2015; 10(9):e0137646. PubMed ID: 26359860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands.
    Karasar P; Esendagli G
    Breast Cancer Res Treat; 2014 Jun; 145(3):605-14. PubMed ID: 24816762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of host factors on neutrophil functions in response to Burkholderia pseudomallei in healthy Thai subjects.
    Saengmuang P; Kewcharoenwong C; Tippayawat P; Nithichanon A; Buddhisa S; Lertmemongkolchai G
    Jpn J Infect Dis; 2014; 67(6):436-40. PubMed ID: 25410558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of IL-22-producing T helper 22 cells by RPE cells via PD-L1/PD-1 interactions.
    Sugita S; Kawazoe Y; Imai A; Usui Y; Takahashi M; Mochizuki M
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6926-33. PubMed ID: 24065812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of innate immune responses to Burkholderia pseudomallei in human blood identifies a central role for lipopolysaccharide.
    Chantratita N; Tandhavanant S; Myers ND; Seal S; Arayawichanont A; Kliangsa-Ad A; Hittle LE; Ernst RK; Emond MJ; Wurfel MM; Day NP; Peacock SJ; West TE
    PLoS One; 2013; 8(11):e81617. PubMed ID: 24303060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Control of
    Nithichanon A; Rinchai D; Buddhisa S; Saenmuang P; Kewcharoenwong C; Kessler B; Khaenam P; Chetchotisakd P; Maillere B; Robinson J; Reynolds CJ; Boyton RJ; Altmann DM; Lertmemongkolchai G
    Front Immunol; 2018; 9():484. PubMed ID: 29616023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.